Mammals aren’t known for the ocular regenerative powers, but a new study shows that nature has a few tricks up its sleeve.

For decades, restoring sight after severe eye damage sat firmly in the realm of science fiction. Now a wave of converging ...

Elon Musk recently pronounced that the next Neuralink project will be a “Blindsight” cortical implant to restore vision: “Resolution will be low at first, like early Nintendo graphics, but ultimately ...

Scientists in Canada have developed a new technique that may one day help restore some sight to patients with inherited vision impairment. The regenerative therapy works by expressing genes that ...

Please provide your email address to receive an email when new articles are posted on . Advanced Research Projects Agency for Health has launched a program to restore vision through whole eye ...

Please provide your email address to receive an email when new articles are posted on . Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE ...

A radical stem cell transplant has significantly improved the blurry vision of three people with severe damage to their cornea. The clinical trial, which took place in Japan, is the first of its kind ...

The case marks the first time sight has been partially restored using optogenetics, a type of biological research aimed at controlling nerve cells via light. Jackson Ryan was CNET's science editor, ...

For some degenerative vision disorders, the therapies available don’t restore sight, they mainly slow its decline. To realize this benefit, a patient must receive an eye injection as frequently as ...

Imagine slowly losing the center of your vision, like a camera lens fading to fog. That's what happens with geographic atrophy, a severe form of age-related macular degeneration (AMD). It's the ...

A group of scientists restored vision in a monkey by using human stem cells to fix a hole in its retina. The research could open new doors for vision treatment in humans and other animals, too. A new ...

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. RV-001 a gene-agnostic approach for RP patients.